Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Commandité

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posté

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Connectez-vous pour aimer, partager et commenter!

National economy moving towards positive direction: PM Oli

KATHMANDU: Prime Minister KP Sharma Oli has said that the country’s economy is moving...

Par 0 4

Government to auction Rs 27,000 crore in securities, split into two tranches

The government is set to re-issue dated government securities totaling Rs 27,000 crore on Friday,...

Par 0 5

RBSE Science, Commerce Results 2025: High pass percentages, Girls outshine boys again

Par 0 26

Public hope towards Maoist increasing: Chair Dahal

BAGLUNG: CPN (Maoist Centre) chair Pushpa Kamal Dahal ‘Prachanda’ has stated that the...

Par 0 30

Baburam Bhattarai walks off stage after controversial remark on armed conflict deaths sparks protest

KATHMANDU: Former Prime Minister Dr. Baburam Bhattarai faced backlash and was forced to...

Par 0 31